Highly efficacious, long-term, triglyceride lowering with rituximab therapy in a patient with autoimmune hypertriglyceridemia

We report the first case of an autoimmune hypertriglyceridemia successfully treated with rituximab, an anti-CD20-targeted monoclonal antibody. A 45-year-old man, with prior autoimmune conditions, developed severe, acquired hypertriglyceridemia resistant to traditional triglyceride lowering therapies...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical lipidology 2018-07, Vol.12 (4), p.883-887
Hauptverfasser:	Béliard, Sophie, Di Filippo, Mathilde, Kaplanski, Gilles, Valéro, René
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-LPL autoantibody Autoimmune hyperlipidemia Endocrinology and metabolism Human health and pathology Hyperchylomicronemia Life Sciences Rituximab Type 1 hyperlipidemia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!